Fábio M. Iwamoto

Cornell University — United States

Medicine · Health Sciences

50h-index11.7kcitations395works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(213), Brain Metastases and Treatment(83), Cancer Immunotherapy and Biomarkers(62), Cancer Genomics and Diagnostics(53), CNS Lymphoma Diagnosis and Treatment(36)

Publications390 total

[68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response Biomarker
American Journal of Neuroradiology·2026Open Access
Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery
Journal of Clinical Oncology·2026
Table S5 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025Open Access
Key Resources Table from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025Open Access
Table S4 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025Open Access
Table S3 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025Open Access
Table S7 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025Open Access
Table S8 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025Open Access
Table S1 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025Open Access
Table S2 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025Open Access
Supplementary Figures S1-S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025Open Access
Table S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025Open Access
Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma
American Journal of Neuroradiology·2025Open Access
Supplementary Tables S1-S3 from <i>MGMT</i> Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas
2025Open Access
Supplementary Figures S1-S6 from <i>MGMT</i> Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas
2025Open Access
BIOM-48. MOLECULAR AND RADIOLOGICAL MARKERS ASSOCIATED WITH MALIGNANT TRANSFORMATION IN IDH1 MUTANT LOW-GRADE GLIOMAS
Neuro-Oncology·2025Open Access
BIOM-69. TP53-DRIVEN IMMUNOSUPPRESSIVE MICROENVIRONMENT UNDERLIES ANTI-PD1 RESISTANCE IN GLIOBLASTOMA
Neuro-Oncology·2025Open Access
CTNI-68. C/EBPβ INHIBITION BY LUCICEBTIDE IN A WINDOW-OF-OPPORTUNITY SURGICAL TRIAL FOR GLIOBLASTOMA SUPPRESSES THE MESENCHYMAL PHENOTYPE AND PROMOTES AN IMMUNOSTIMULATORY TUMOR MICROENVIRONMENT
Neuro-Oncology·2025Open Access
RADT-33. PROGNOSTIC AND PREDICTIVE EFFECT OF AGE IN MOLECULARLY-DEFINED LOWER GRADE GLIOMAS: A REPORT FROM THE PROSPECTIVE GLIOMA RESEARCH (PROGRES) DATABASE
Neuro-Oncology·2025Open Access
IMG-63. Clinical Utility of 18F-FLUCICLOVINE PET/MRI for Differentiating True Progression from Treatment Effects in Glioblastoma
Neuro-Oncology·2025Open Access
page 1 of 20Next →

Frequent Co-authors

Lauren E. Abrey(18), Lisa M. DeAngelis(12), Jeffrey N. Bruce(7), Lakshmi Nayak(7), Andrew B. Lassman(7), Howard A. Fine(6), Katherine S. Panageas(6), Nicholas Butowski(5), Samuel Goldlust(5), James Perry(5), Timothy F. Cloughesy(5), Teri Kreisl(5), Joohee Sul(5), Marc K. Rosenblum(5), Jan Drappatz(4), Roger Stupp(4), Daniela A. Bota(4), Michael Cloney(4), Peter Canoll(4), David Piccioni(4)